How Ph.D. was paid
$2.7M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Stock | Options | Other | Total |
|---|---|---|---|---|---|
| Peter Blume-Jensen, M.D., Ph.D.Chief Executive Officer, President and Director | $709,893 | $1,592,245 | $410,400 | $6,000 | $2,718,538 |
| Kristina Masson, Ph.D, M.B.A.Executive Vice President, Business Operations, Director | $594,472 | $573,206 | $251,248 | $6,000 | $1,424,926 |
| Eric Devroe, Ph.D.Chief Operating Officer | $528,745 | $573,206 | $250,052 | $6,000 | $1,358,003 |
What changed and why
- $2.7MChief executive officer total compensation increased to $2,718,538 for fiscal 2025 from $2,000,312 in the prior year.
- Base salaries for named executive officers were increased in early 2025 by the compensation committee.
- Named executive officers were granted exclusively stock options rather than a mix of options and restricted stock units for 2025.
- Annual performance bonuses were determined based on corporate and individual objectives established by the board.
- All option awards were granted with a per share exercise price equal to fair market value on the grant date.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.